PCI Biotech: Mandatory notification of trade Th
Post# of 301275
The Chairman Hans Peter Bøhn has today, 14 December 2016, subscribed for 33.556 new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of NOK 7 per share by exercising 33.556 subscription rights in the Company's ongoing rights issue. After the transaction, Hans Peter Bøhn will have a total shareholding in the company of 83.556 shares and 0 subscription rights in the rights issue. Hans Peter Bøhn has previously entered into a guarantee agreement of NOK 1 000 000 in relation to the rights issue, and todays exercise of subscription rights will, in compliance with the guarantee agreement, reduce the guarantee liability correspondingly.
Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
(0)
(0)